SCHEMBL1492785

SCHEMBL1492785

COc1ccc(C(C)(C)C)cc1NC(=O)Nc1ccc(-c2ccnc(C)c2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 5/20 0.57
PSEN2 P49810 5/20 0.57
APH1B Q8WW43 5/20 0.57
NCSTN Q92542 5/20 0.57
APH1A Q96BI3 5/20 0.57
PSENEN Q9NZ42 5/20 0.57
HTT P42858 3/20 0.55
MAPT P10636 3/20 0.55
LMNA P02545 2/20 0.55
HSP90AA1 P07900 1/20 0.55
RECQL P46063 1/20 0.55
RAF1 P04049 4/20 0.52
IDO1 P14902 1/20 0.52
MAPK14 Q16539 1/20 0.51
TSHR P16473 1/20 0.49
MAPK1 P28482 2/20 0.48
MEN1 O00255 2/20 0.48
TP53 P04637 2/20 0.48
KMT2A Q03164 2/20 0.48
GAA P10253 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1492973 0.91 PSEN1 (0.68) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1492820 0.87 MAPT (0.65) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1492687 0.86 PORCN (0.60) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1493084 0.85 MEN1 (0.58) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1492881 0.85 PSEN1 (0.56) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1492989 0.84 SMN1; SMN2 (0.62) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL27809648 0.82 PSEN1 (0.57) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1492866 0.81 MEN1 (0.61) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1492969 0.80 PSEN1 (0.67) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1492788 0.79 HTR2C (0.57) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US claimed
EP-2300427-A1 UREA COMPOUNDS AS GAMMA SECRETASE MODULATORS AMGEN INC. (US) 2011-03-30 EP claimed
WO-2009137404-A1 UREA COMPOUNDS AS GAMMA SECRETASE MODULATORS AMGEN INC. (US) 2009-11-12 WO claimed
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US disclosed
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators BACE1, BACE2, PSEN1 PSEN1 3/4885PSEN2 4/4885APH1B 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.